Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Marija Dobratic"'
Autor:
Susan L. Cohn, Philip P. Connell, Yusuke Nakamura, Emma Wilkinson, Mark A. Applebaum, Ryan Miller, Jae-Hyun Park, Brian Budke, Helen R. Salwen, Marija Dobratic, Chanyoung Park, Alexandre Chlenski
MYCN/MYC expression in N-type and S-type neuroblastoma cell lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03019b2e4e013bb650ca3b7c2f1f466a
https://doi.org/10.1158/1535-7163.22507038.v1
https://doi.org/10.1158/1535-7163.22507038.v1
Autor:
Susan L. Cohn, Philip P. Connell, Yusuke Nakamura, Emma Wilkinson, Mark A. Applebaum, Ryan Miller, Jae-Hyun Park, Brian Budke, Helen R. Salwen, Marija Dobratic, Chanyoung Park, Alexandre Chlenski
Maternal embryonic leucine zipper kinase (MELK) activates pathways that mediate aggressive tumor growth and therapy resistance in many types of adult cancers. Pharmacologic and genomic inhibition of MELK impairs tumor growth and increases sensitivity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4febb23c7b71f32373ae7d55f84061a
https://doi.org/10.1158/1535-7163.c.6538560.v1
https://doi.org/10.1158/1535-7163.c.6538560.v1
Autor:
Susan L. Cohn, Philip P. Connell, Yusuke Nakamura, Emma Wilkinson, Mark A. Applebaum, Ryan Miller, Jae-Hyun Park, Brian Budke, Helen R. Salwen, Marija Dobratic, Chanyoung Park, Alexandre Chlenski
pRPA32 expression in neuroblastoma cells treated with OTS167 and CPT.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c58ba688ff09dc1f2df1acdca3bfff2b
https://doi.org/10.1158/1535-7163.22507032
https://doi.org/10.1158/1535-7163.22507032
Autor:
Susan L. Cohn, Philip P. Connell, Yusuke Nakamura, Emma Wilkinson, Mark A. Applebaum, Ryan Miller, Jae-Hyun Park, Brian Budke, Helen R. Salwen, Marija Dobratic, Chanyoung Park, Alexandre Chlenski
MELK and EZH2 RNA expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::862a748e7b00f5b7ddeeccda910c3a1d
https://doi.org/10.1158/1535-7163.22507035.v1
https://doi.org/10.1158/1535-7163.22507035.v1
Autor:
Jason Karpus, Sheng Zhang, Chuan He, Marija Dobratic, Mark A. Applebaum, Wei Zhang, Alexandre Chlenski, Erin K. Barr, Emma Wilkinson, Lucy A. Godley, Susan L. Cohn, Barbara E. Stranger, Elizabeth A. Sokol, Robert L. Grossman, Meritxell Oliva, Diana C. West-Szymanski, Helen R. Salwen, Zhou Zhang
Publikováno v:
Clin Cancer Res
Purpose: 5-Hydroxymethylcytosine (5-hmC) is an epigenetic marker of open chromatin and active gene expression. We profiled 5-hmC with Nano-hmC-Seal technology using 10 ng of plasma-derived cell-free DNA (cfDNA) in blood samples from patients with neu
Autor:
Jason Karpus, Sakshi Uppal, Lucy A. Godley, Zhou Zhang, Amy E. Armstrong, Susan L. Cohn, Wei Zhang, Erin K. Barr, Barbara E. Stranger, Emma Wilkinson, Chuan He, Robert L. Grossman, Madina Sukhanova, Helen R. Salwen, Alexandre Chlenski, Mark A. Applebaum, Marija Dobratic, Ji Nie
Publikováno v:
JCO precision oncology
PURPOSE Whole-genome profiles of the epigenetic modification 5-hydroxymethylcytosine (5-hmC) are robust diagnostic biomarkers in adult patients with cancer. We investigated if 5-hmC profiles would serve as novel prognostic markers in neuroblastoma, a
Autor:
Alexandre Chlenski, Emma Wilkinson, Marija Dobratic, Chanyoung Park, Yusuke Nakamura, Ryan Miller, Brian Budke, Susan L. Cohn, Jae-Hyun Park, Mark A. Applebaum, Philip P. Connell, Helen R. Salwen
Publikováno v:
Molecular Cancer Therapeutics. 18:507-516
Maternal embryonic leucine zipper kinase (MELK) activates pathways that mediate aggressive tumor growth and therapy resistance in many types of adult cancers. Pharmacologic and genomic inhibition of MELK impairs tumor growth and increases sensitivity
Autor:
Susan L. Cohn, Lisa J. Guerrero, Mark A. Applebaum, Ryan Miller, Jeremy D. Marks, Helen R. Salwen, Marija Dobratic, Gillian DeWane, Alexandre Chlenski, Elena Solomaha
Publikováno v:
Oncotarget
// Alexandre Chlenski 1 , Marija Dobratic 1 , Helen R. Salwen 1 , Mark Applebaum 1 , Lisa J. Guerrero 1 , Ryan Miller 1 , Gillian DeWane 1 , Elena Solomaha 2 , Jeremy D. Marks 1 , Susan L. Cohn 1 1 Department of Pediatrics, University of Chicago, Chi
Autor:
Kyle M. Hernandez, Nanduri R. Prabhakar, Lucy A. Godley, Aashish R. Jha, Susan L. Cohn, Barbara E. Stranger, Christopher J. Mariani, Kevin P. White, Helen R. Salwen, Gillian DeWane, Alexandre Chlenski, Clara Kao, Marija Dobratic, Mark A. Applebaum
Publikováno v:
Oncotarget
// Mark A. Applebaum 1, 2, * , Aashish R. Jha 3, 4, * , Clara Kao 4 , Kyle M. Hernandez 5 , Gillian DeWane 1 , Helen R. Salwen 1 , Alexandre Chlenski 1 , Marija Dobratic 1 , Christopher J. Mariani 6 , Lucy A. Godley 6 , Nanduri Prabhakar 6 , Kevin Wh
Autor:
Marija Dobratic, Chuan He, Meritxell Oliva, Jason Karpus, Alexandre Chlenski, Erin K. Barr, Mark A. Applebaum, Emma Wilkinson, Elizabeth A. Sokol, Helen R. Salwen, Susan L. Cohn, Barbara E. Stranger
Publikováno v:
Cancer Research. 80:B02-B02
Background: 5-Hydroxymethylcytosine (5-hmC) is an epigenetic marker of open chromatin and active gene expression. The level of 5-hmC expression serves as a biomarker in adults with cancer, and we recently demonstrated the prognostic significance of t